Sherbrooke Park Advisers LLC Spring Works Therapeutics, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 7,956 shares of SWTX stock, worth $326,196. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,956Holding current value
$326,196% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
239Shares Held
70MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$275 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$230 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$158 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$144 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$140 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.56B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...